Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daniel Louis Hertz"'
Autor:
Thomas Helland, Bjørn Naume, Steinar Hustad, Ersilia Bifulco, Jan Terje Kvaløy, Anna Barbro Sætersdal, Marit Synnestvedt, Tone Hoel Lende, Bjørnar Gilje, Ingvil Mjaaland, Kjetil Weyde, Egil Støre Blix, Gro Wiedswang, Elin Borgen, Daniel Louis Hertz, Emiel Adrianus Maria Janssen, Gunnar Mellgren, Håvard Søiland
Publikováno v:
Molecular Oncology, Vol 15, Iss 4, Pp 957-967 (2021)
Low steady‐state levels of active tamoxifen metabolites have been associated with inferior treatment outcomes. In this retrospective analysis of 406 estrogen receptor‐positive breast cancer (BC) patients receiving adjuvant tamoxifen as initial tr
Externí odkaz:
https://doaj.org/article/162b341b32bb451fafcf55ad582ca776
Autor:
Meghna S. Trivedi, Joseph M. Unger, Dawn L. Hershman, Amy Darke, Daniel Louis Hertz, Thomas Brannagan, Stephanie Smith, William Johnson Irvin, Amanda Redden Hathaway, Amy C. Vander Woude, Vinay K. Gudena, Norah Lynn Henry, Michael Jordan Fisch
Publikováno v:
Journal of Clinical Oncology. 40:12024-12024
12024 Background: Chemotherapy induced peripheral neuropathy (CIPN) can lead to treatment dose reduction or discontinuation and significantly impact quality of life and functional status. Clinical trials have historically excluded patients with pre-e
Autor:
Ciao-Sin Chelsea Chen, Gary Zirpoli, Susan McCann, William E. Barlow, George Thomas Budd, Lajos Pusztai, Gabriel N. Hortobagyi, Andrew K. Godwin, Alastair Mark Thompson, Christine B. Ambrosone, Kathleen A Stringer, Daniel Louis Hertz
Publikováno v:
Journal of Clinical Oncology. 40:12023-12023
12023 Background: Peripheral neuropathy (PN) is a treatment-limiting toxicity of paclitaxel. Black patients have higher rates of PN and vitamin D insufficiency, and our prior work suggests vitamin D insufficiency increases risk of paclitaxel-induced